Literature DB >> 17711101

Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.

Piotr Socha1, Aldona Wierzbicka, Joanna Neuhoff-Murawska, Dariusz Włodarek, Jerzy Podleśny, Jerzy Socha.   

Abstract

The main criteria of the metabolic syndrome are obesity, insulin resistance and disturbed lipid metabolism. The same disturbances are regarded to be involved into the pathomechanism of nonalcoholic fatty liver disease which is shown by epidemiological studies and animal models. Thus NAFLD can be regarded a specific feature of the metabolic syndrome and it should be looked for in high risk populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17711101

Source DB:  PubMed          Journal:  Rocz Panstw Zakl Hig        ISSN: 0035-7715


  11 in total

1.  Pancreatic cancer: risk and preventive factors.

Authors:  Anna Licata; Giuseppe Montalto; Maurizio Soresi
Journal:  Intern Emerg Med       Date:  2018-02-07       Impact factor: 3.397

2.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

3.  PPARα-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling.

Authors:  Huiying Hua; Julin Yang; Hante Lin; Yang Xi; Manyun Dai; Gangming Xu; Fuyan Wang; Lihong Liu; Tingqi Zhao; Jing Huang; Frank J Gonzalez; Aiming Liu
Journal:  J Pharm Pharmacol       Date:  2018-09-25       Impact factor: 3.765

4.  Acupuncture for type 2 diabetes mellitus with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.

Authors:  Mengyuan Li; Lin Yao; Haipeng Huang; Guan Wang; Bin Yu; Haizhu Zheng; Hongfeng Wang
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

5.  Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.

Authors:  Sheng-Jie Wu; Gui-Qi Zhu; Bo-Zhi Ye; Fan-Qi Kong; Zai-Xing Zheng; Hai Zou; Ke-Qing Shi; Lu Lin; Martin Braddock; Wei-Jian Huang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.

Authors:  Xiaoya Zheng; Lilin Gong; Rong Luo; Hua Chen; Bin Peng; Wei Ren; Yonghong Wang
Journal:  Lipids Health Dis       Date:  2017-10-16       Impact factor: 3.876

7.  Association between ADIPOQ G276T and C11377G polymorphisms and the risk of non-alcoholic fatty liver disease: An updated meta-analysis.

Authors:  Mengwei Liu; Shan Liu; Mengke Shang; Xiuping Liu; Yue Wang; Qian Li; Michael Mambiya; Luping Yang; Qian Zhang; Kaili Zhang; Fangfang Nie; Fanxin Zeng; Wanyang Liu
Journal:  Mol Genet Genomic Med       Date:  2019-03-05       Impact factor: 2.183

8.  Effects of Exenatide and Humalog Mix25 on Fat Distribution, Insulin Sensitivity, and β-Cell Function in Normal BMI Patients with Type 2 Diabetes and Visceral Adiposity.

Authors:  Xinlei Wang; Xiaoqin Zhao; Yunjuan Gu; Xiaohui Zhu; Tong Yin; Zhuqi Tang; Jin Yuan; Wei Chen; Rong OuYang; Lili Yao; Rongping Zhang; Jie Yuan; Ranran Zhou; Yi Sun; Shiwei Cui
Journal:  J Diabetes Res       Date:  2020-05-26       Impact factor: 4.011

9.  Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.

Authors:  Priyanka Nigam; Surya P Bhatt; Anoop Misra; Meera Vaidya; Jharna Dasgupta; Davinder Singh Chadha
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease.

Authors:  Quelson Coelho Lisboa; Mateus Jorge Nardelli; Patrícia de Araújo Pereira; Débora Marques Miranda; Stephanie Nunes Ribeiro; Raissa Soares Neves Costa; Camila Azevedo Versiani; Paula Vieira Teixeira Vidigal; Teresa Cristina de Abreu Ferrari; Claudia Alves Couto
Journal:  World J Hepatol       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.